BCL2L1 and head and neck squamous cell carcinoma: Similar effects were reported in head and neck squamous cell carcinoma (HNSCC) cell lines, in which palbociclib-induced BCL-xL-dependent senescence caused a decrease in cell survival and an increase in apoptosis in the presence of navitoclax [37].